Register

I agree with the Privacy Policy

In The News

How mHealth developers can avoid ethical dilemmas

October 19, 2015

connected health devices

Fierce Healthcare

The ethical issues around mHealth are one reason consumers are wary of health devices, and many deal closely with the privacy of what is a person's most private information. A recent Parks Associates report found that about 35 percent of consumers say they fear their health data will not remain confidential if put online, and 23 percent of broadband household owners cite privacy and security concerns in using connected health devices.

The JMIR viewpoint's authors add that there currently is no regulation of mHealth devices or apps, and no guarantee that they provide clinically accurate information. However, this summer the U.S. Food and Drug Administration released guidelines for how it intends to regulate the marketing of mHealth apps that meet the definition of medical devices.

From the article "How mHealth developers can avoid ethical dilemmas" by Judy Mottl.

Previously In The News

Nest announces new hardware products in answer to critics

Tom Kerber, a director overseeing Internet-of-things strategy for Parks Associates, said sales for video doorbells have grown dramatically in recent years because of the popularity of online shopping....

Netflix Is Killing It—Big Time—After Pouring Cash Into Original Shows

“There seemed to be an attitude around the industry that after House of Cards and Orange is the New Black, there was no way Netflix could catch lightning in a bottle again,” says Glenn Hower, a senior...

Roku Plunges: 3 Reasons to Buy, 4 Reasons to Sell

Last August, Parks Associates reported that Roku controlled 37% of the streaming device market in the U.S., while Amazon, Google, and Apple held shares of 24%, 18%, and 15%, respectively. All three of...

The Simple Reason Why I Won't Buy Roku Inc.

Roku (NASDAQ:ROKU) went public on Sep. 28, its stock surging nearly 70% from its IPO price of $14 per share. The stock hit almost $30 the following day, but subsequently pulled back to the low $20s....

‹
1
2
...
347
348
349
350
351
352
353
...
745
746
›